nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—UGT1A1—Mycophenolic acid—psoriasis	0.066	0.088	CbGbCtD
Etoposide—ABCC10—Cyclosporine—psoriasis	0.0595	0.0793	CbGbCtD
Etoposide—ABCC3—Cyclosporine—psoriasis	0.0374	0.0499	CbGbCtD
Etoposide—UGT1A1—Mycophenolate mofetil—psoriasis	0.0369	0.0492	CbGbCtD
Etoposide—ABCC10—Methotrexate—psoriasis	0.0315	0.042	CbGbCtD
Etoposide—CYP2C8—Tazarotene—psoriasis	0.0292	0.0389	CbGbCtD
Etoposide—CYP3A5—Beclomethasone—psoriasis	0.0282	0.0376	CbGbCtD
Etoposide—CYP1A2—Clobetasol propionate—psoriasis	0.0277	0.037	CbGbCtD
Etoposide—ABCC1—Cyclosporine—psoriasis	0.023	0.0306	CbGbCtD
Etoposide—ABCC2—Mycophenolate mofetil—psoriasis	0.0224	0.0299	CbGbCtD
Etoposide—PTGS2—Triamcinolone—psoriasis	0.0222	0.0296	CbGbCtD
Etoposide—ABCG2—Mycophenolate mofetil—psoriasis	0.0203	0.027	CbGbCtD
Etoposide—ABCC3—Methotrexate—psoriasis	0.0198	0.0264	CbGbCtD
Etoposide—PTGS2—Betamethasone—psoriasis	0.019	0.0254	CbGbCtD
Etoposide—ABCC2—Cyclosporine—psoriasis	0.017	0.0227	CbGbCtD
Etoposide—ABCG2—Hydrocortisone—psoriasis	0.0163	0.0217	CbGbCtD
Etoposide—ABCG2—Cyclosporine—psoriasis	0.0154	0.0205	CbGbCtD
Etoposide—CYP1A2—Methoxsalen—psoriasis	0.0146	0.0194	CbGbCtD
Etoposide—CYP2C8—Cholecalciferol—psoriasis	0.0125	0.0166	CbGbCtD
Etoposide—ABCC1—Methotrexate—psoriasis	0.0121	0.0162	CbGbCtD
Etoposide—CYP3A5—Mycophenolate mofetil—psoriasis	0.0112	0.015	CbGbCtD
Etoposide—ABCC2—Dexamethasone—psoriasis	0.0112	0.0149	CbGbCtD
Etoposide—PTGS2—Dexamethasone—psoriasis	0.0111	0.0148	CbGbCtD
Etoposide—CYP2C8—Mycophenolate mofetil—psoriasis	0.0108	0.0144	CbGbCtD
Etoposide—ABCG2—Dexamethasone—psoriasis	0.0101	0.0135	CbGbCtD
Etoposide—CYP3A4—Calcitriol—psoriasis	0.0098	0.0131	CbGbCtD
Etoposide—CYP3A5—Hydrocortisone—psoriasis	0.00901	0.012	CbGbCtD
Etoposide—ABCC2—Methotrexate—psoriasis	0.00899	0.012	CbGbCtD
Etoposide—ABCC6—dermis—psoriasis	0.00885	0.442	CbGeAlD
Etoposide—CYP2C8—Hydrocortisone—psoriasis	0.00866	0.0116	CbGbCtD
Etoposide—CYP3A5—Cyclosporine—psoriasis	0.00851	0.0114	CbGbCtD
Etoposide—CYP2C8—Cyclosporine—psoriasis	0.00818	0.0109	CbGbCtD
Etoposide—ABCG2—Methotrexate—psoriasis	0.00813	0.0108	CbGbCtD
Etoposide—CYP3A4—Methoxsalen—psoriasis	0.00762	0.0102	CbGbCtD
Etoposide—ABCB1—Mycophenolate mofetil—psoriasis	0.00731	0.00975	CbGbCtD
Etoposide—CYP2E1—Dexamethasone—psoriasis	0.00721	0.00963	CbGbCtD
Etoposide—ABCB1—Betamethasone—psoriasis	0.00627	0.00837	CbGbCtD
Etoposide—ABCB1—Prednisolone—psoriasis	0.00619	0.00826	CbGbCtD
Etoposide—ABCB1—Hydrocortisone—psoriasis	0.00587	0.00783	CbGbCtD
Etoposide—ABCB1—Prednisone—psoriasis	0.00584	0.0078	CbGbCtD
Etoposide—CYP3A5—Dexamethasone—psoriasis	0.0056	0.00748	CbGbCtD
Etoposide—ABCB1—Cyclosporine—psoriasis	0.00554	0.00739	CbGbCtD
Etoposide—CYP2C8—Dexamethasone—psoriasis	0.00539	0.00719	CbGbCtD
Etoposide—CYP3A4—Cholecalciferol—psoriasis	0.00505	0.00674	CbGbCtD
Etoposide—CYP3A4—Triamcinolone—psoriasis	0.00438	0.00584	CbGbCtD
Etoposide—CYP3A4—Mycophenolate mofetil—psoriasis	0.00438	0.00584	CbGbCtD
Etoposide—CYP3A4—Betamethasone—psoriasis	0.00376	0.00501	CbGbCtD
Etoposide—CYP3A4—Prednisolone—psoriasis	0.00371	0.00495	CbGbCtD
Etoposide—ABCB1—Dexamethasone—psoriasis	0.00365	0.00487	CbGbCtD
Etoposide—CYP3A4—Hydrocortisone—psoriasis	0.00351	0.00469	CbGbCtD
Etoposide—CYP3A4—Prednisone—psoriasis	0.0035	0.00467	CbGbCtD
Etoposide—CYP3A4—Cyclosporine—psoriasis	0.00332	0.00443	CbGbCtD
Etoposide—ABCB1—Methotrexate—psoriasis	0.00293	0.00391	CbGbCtD
Etoposide—CYP3A4—Dexamethasone—psoriasis	0.00219	0.00292	CbGbCtD
Etoposide—PTGS2—skeletal joint—psoriasis	0.00203	0.101	CbGeAlD
Etoposide—PTGS2—synovial membrane of synovial joint—psoriasis	0.00154	0.0769	CbGeAlD
Etoposide—PTGS2—skin epidermis—psoriasis	0.000987	0.0493	CbGeAlD
Etoposide—TOP2B—tendon—psoriasis	0.000796	0.0398	CbGeAlD
Etoposide—PTGS1—endothelium—psoriasis	0.000749	0.0375	CbGeAlD
Etoposide—PTGS2—endothelium—psoriasis	0.000716	0.0358	CbGeAlD
Etoposide—GSTP1—skin of body—psoriasis	0.000655	0.0328	CbGeAlD
Etoposide—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.000608	0.148	CbGdCrCtD
Etoposide—TOP2A—tendon—psoriasis	0.000586	0.0293	CbGeAlD
Etoposide—GSTP1—tendon—psoriasis	0.000499	0.0249	CbGeAlD
Etoposide—ABCC10—tendon—psoriasis	0.000499	0.0249	CbGeAlD
Etoposide—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.000487	0.119	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.000473	0.115	CbGdCrCtD
Etoposide—ABCC2—tendon—psoriasis	0.0004	0.02	CbGeAlD
Etoposide—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.000367	0.0893	CbGdCrCtD
Etoposide—ABCC1—tendon—psoriasis	0.000353	0.0176	CbGeAlD
Etoposide—PTGS1—skin of body—psoriasis	0.00032	0.016	CbGeAlD
Etoposide—PTGS2—skin of body—psoriasis	0.000306	0.0153	CbGeAlD
Etoposide—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	0.000294	0.0715	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	0.000294	0.0715	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.000285	0.0695	CbGdCrCtD
Etoposide—CYP2E1—tendon—psoriasis	0.000253	0.0126	CbGeAlD
Etoposide—PTGS1—tendon—psoriasis	0.000243	0.0122	CbGeAlD
Etoposide—PTGS2—tendon—psoriasis	0.000233	0.0116	CbGeAlD
Etoposide—PTGS2—Fluocinonide—Dexamethasone—psoriasis	0.000222	0.054	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Betamethasone—psoriasis	0.000222	0.054	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Triamcinolone—psoriasis	0.000217	0.0528	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	0.000134	0.0326	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	0.000134	0.0326	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	0.000131	0.0319	CbGdCrCtD
Etoposide—Renal failure—Methotrexate—psoriasis	9.44e-05	0.000482	CcSEcCtD
Etoposide—Decreased appetite—Mycophenolate mofetil—psoriasis	9.4e-05	0.00048	CcSEcCtD
Etoposide—Anorexia—Hydrocortisone—psoriasis	9.39e-05	0.000479	CcSEcCtD
Etoposide—Diarrhoea—Mycophenolic acid—psoriasis	9.37e-05	0.000479	CcSEcCtD
Etoposide—Stomatitis—Methotrexate—psoriasis	9.36e-05	0.000478	CcSEcCtD
Etoposide—Angiopathy—Prednisone—psoriasis	9.36e-05	0.000478	CcSEcCtD
Etoposide—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	9.34e-05	0.000477	CcSEcCtD
Etoposide—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	9.33e-05	0.00304	CbGpPWpGaD
Etoposide—Immune system disorder—Prednisone—psoriasis	9.32e-05	0.000476	CcSEcCtD
Etoposide—Malaise—Dexamethasone—psoriasis	9.3e-05	0.000475	CcSEcCtD
Etoposide—Malaise—Betamethasone—psoriasis	9.3e-05	0.000475	CcSEcCtD
Etoposide—Anaphylactic shock—Triamcinolone—psoriasis	9.28e-05	0.000473	CcSEcCtD
Etoposide—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	9.27e-05	0.00302	CbGpPWpGaD
Etoposide—Vertigo—Dexamethasone—psoriasis	9.27e-05	0.000473	CcSEcCtD
Etoposide—Vertigo—Betamethasone—psoriasis	9.27e-05	0.000473	CcSEcCtD
Etoposide—PTGS1—Overview of nanoparticle effects—IL6—psoriasis	9.26e-05	0.00302	CbGpPWpGaD
Etoposide—Pain—Mycophenolate mofetil—psoriasis	9.25e-05	0.000472	CcSEcCtD
Etoposide—Constipation—Mycophenolate mofetil—psoriasis	9.25e-05	0.000472	CcSEcCtD
Etoposide—Infection—Triamcinolone—psoriasis	9.22e-05	0.00047	CcSEcCtD
Etoposide—Hypotension—Hydrocortisone—psoriasis	9.21e-05	0.00047	CcSEcCtD
Etoposide—Feeling abnormal—Cyclosporine—psoriasis	9.13e-05	0.000466	CcSEcCtD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	9.13e-05	0.00298	CbGpPWpGaD
Etoposide—Alopecia—Prednisone—psoriasis	9.12e-05	0.000465	CcSEcCtD
Etoposide—PTGS2—Overview of nanoparticle effects—TNF—psoriasis	9.11e-05	0.00297	CbGpPWpGaD
Etoposide—Hepatobiliary disease—Methotrexate—psoriasis	9.08e-05	0.000464	CcSEcCtD
Etoposide—Gastrointestinal pain—Cyclosporine—psoriasis	9.06e-05	0.000463	CcSEcCtD
Etoposide—Loss of consciousness—Betamethasone—psoriasis	9.06e-05	0.000463	CcSEcCtD
Etoposide—Loss of consciousness—Dexamethasone—psoriasis	9.06e-05	0.000463	CcSEcCtD
Etoposide—Dizziness—Mycophenolic acid—psoriasis	9.06e-05	0.000462	CcSEcCtD
Etoposide—Paraesthesia—Prednisolone—psoriasis	9.06e-05	0.000462	CcSEcCtD
Etoposide—Tachycardia—Triamcinolone—psoriasis	9.05e-05	0.000462	CcSEcCtD
Etoposide—Hyperhidrosis—Triamcinolone—psoriasis	8.97e-05	0.000458	CcSEcCtD
Etoposide—GSTP1—Metabolism—NDUFA5—psoriasis	8.96e-05	0.00293	CbGpPWpGaD
Etoposide—Agranulocytosis—Methotrexate—psoriasis	8.96e-05	0.000458	CcSEcCtD
Etoposide—Convulsion—Betamethasone—psoriasis	8.94e-05	0.000456	CcSEcCtD
Etoposide—Convulsion—Dexamethasone—psoriasis	8.94e-05	0.000456	CcSEcCtD
Etoposide—Feeling abnormal—Mycophenolate mofetil—psoriasis	8.91e-05	0.000455	CcSEcCtD
Etoposide—Hypertension—Betamethasone—psoriasis	8.9e-05	0.000454	CcSEcCtD
Etoposide—Hypertension—Dexamethasone—psoriasis	8.9e-05	0.000454	CcSEcCtD
Etoposide—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	8.88e-05	0.0029	CbGpPWpGaD
Etoposide—Paraesthesia—Hydrocortisone—psoriasis	8.85e-05	0.000452	CcSEcCtD
Etoposide—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	8.84e-05	0.000451	CcSEcCtD
Etoposide—TOP2A—Cell Cycle, Mitotic—PTTG1—psoriasis	8.81e-05	0.00288	CbGpPWpGaD
Etoposide—Urticaria—Cyclosporine—psoriasis	8.81e-05	0.000449	CcSEcCtD
Etoposide—Abdominal pain—Cyclosporine—psoriasis	8.76e-05	0.000447	CcSEcCtD
Etoposide—Body temperature increased—Cyclosporine—psoriasis	8.76e-05	0.000447	CcSEcCtD
Etoposide—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	8.75e-05	0.00286	CbGpPWpGaD
Etoposide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.74e-05	0.00285	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—HLA-C—psoriasis	8.73e-05	0.00285	CbGpPWpGaD
Etoposide—Vomiting—Mycophenolic acid—psoriasis	8.71e-05	0.000445	CcSEcCtD
Etoposide—Discomfort—Betamethasone—psoriasis	8.67e-05	0.000443	CcSEcCtD
Etoposide—Discomfort—Dexamethasone—psoriasis	8.67e-05	0.000443	CcSEcCtD
Etoposide—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—psoriasis	8.67e-05	0.00283	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—IL13—psoriasis	8.67e-05	0.00283	CbGpPWpGaD
Etoposide—Rash—Mycophenolic acid—psoriasis	8.64e-05	0.000441	CcSEcCtD
Etoposide—Dermatitis—Mycophenolic acid—psoriasis	8.63e-05	0.000441	CcSEcCtD
Etoposide—Pain—Prednisolone—psoriasis	8.63e-05	0.00044	CcSEcCtD
Etoposide—Urticaria—Mycophenolate mofetil—psoriasis	8.59e-05	0.000438	CcSEcCtD
Etoposide—Headache—Mycophenolic acid—psoriasis	8.58e-05	0.000438	CcSEcCtD
Etoposide—Decreased appetite—Hydrocortisone—psoriasis	8.56e-05	0.000437	CcSEcCtD
Etoposide—Body temperature increased—Mycophenolate mofetil—psoriasis	8.55e-05	0.000436	CcSEcCtD
Etoposide—Abdominal pain—Mycophenolate mofetil—psoriasis	8.55e-05	0.000436	CcSEcCtD
Etoposide—Urinary tract disorder—Methotrexate—psoriasis	8.51e-05	0.000435	CcSEcCtD
Etoposide—Gastrointestinal disorder—Hydrocortisone—psoriasis	8.5e-05	0.000434	CcSEcCtD
Etoposide—Fatigue—Hydrocortisone—psoriasis	8.49e-05	0.000434	CcSEcCtD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	8.46e-05	0.00276	CbGpPWpGaD
Etoposide—Urethral disorder—Methotrexate—psoriasis	8.45e-05	0.000431	CcSEcCtD
Etoposide—Pain—Hydrocortisone—psoriasis	8.42e-05	0.00043	CcSEcCtD
Etoposide—Anaphylactic shock—Betamethasone—psoriasis	8.42e-05	0.00043	CcSEcCtD
Etoposide—Anaphylactic shock—Dexamethasone—psoriasis	8.42e-05	0.00043	CcSEcCtD
Etoposide—Infection—Betamethasone—psoriasis	8.36e-05	0.000427	CcSEcCtD
Etoposide—Infection—Dexamethasone—psoriasis	8.36e-05	0.000427	CcSEcCtD
Etoposide—Ill-defined disorder—Prednisone—psoriasis	8.33e-05	0.000425	CcSEcCtD
Etoposide—Paraesthesia—Triamcinolone—psoriasis	8.33e-05	0.000425	CcSEcCtD
Etoposide—Feeling abnormal—Prednisolone—psoriasis	8.31e-05	0.000424	CcSEcCtD
Etoposide—Anaemia—Prednisone—psoriasis	8.3e-05	0.000424	CcSEcCtD
Etoposide—Dyspnoea—Triamcinolone—psoriasis	8.27e-05	0.000422	CcSEcCtD
Etoposide—Thrombocytopenia—Dexamethasone—psoriasis	8.24e-05	0.000421	CcSEcCtD
Etoposide—Thrombocytopenia—Betamethasone—psoriasis	8.24e-05	0.000421	CcSEcCtD
Etoposide—Tachycardia—Dexamethasone—psoriasis	8.21e-05	0.000419	CcSEcCtD
Etoposide—Tachycardia—Betamethasone—psoriasis	8.21e-05	0.000419	CcSEcCtD
Etoposide—CYP1A2—Biological oxidations—CYP2S1—psoriasis	8.19e-05	0.00267	CbGpPWpGaD
Etoposide—Hypersensitivity—Cyclosporine—psoriasis	8.17e-05	0.000417	CcSEcCtD
Etoposide—Erythema multiforme—Methotrexate—psoriasis	8.15e-05	0.000416	CcSEcCtD
Etoposide—Nausea—Mycophenolic acid—psoriasis	8.14e-05	0.000415	CcSEcCtD
Etoposide—Hyperhidrosis—Dexamethasone—psoriasis	8.14e-05	0.000415	CcSEcCtD
Etoposide—Hyperhidrosis—Betamethasone—psoriasis	8.14e-05	0.000415	CcSEcCtD
Etoposide—Feeling abnormal—Hydrocortisone—psoriasis	8.12e-05	0.000414	CcSEcCtD
Etoposide—Malaise—Prednisone—psoriasis	8.1e-05	0.000413	CcSEcCtD
Etoposide—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	8.08e-05	0.00264	CbGpPWpGaD
Etoposide—Vertigo—Prednisone—psoriasis	8.07e-05	0.000412	CcSEcCtD
Etoposide—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	8.07e-05	0.00263	CbGpPWpGaD
Etoposide—Eye disorder—Methotrexate—psoriasis	8.06e-05	0.000411	CcSEcCtD
Etoposide—Gastrointestinal pain—Hydrocortisone—psoriasis	8.06e-05	0.000411	CcSEcCtD
Etoposide—Anorexia—Betamethasone—psoriasis	8.02e-05	0.00041	CcSEcCtD
Etoposide—Anorexia—Dexamethasone—psoriasis	8.02e-05	0.00041	CcSEcCtD
Etoposide—Urticaria—Prednisolone—psoriasis	8.01e-05	0.000409	CcSEcCtD
Etoposide—Cardiac disorder—Methotrexate—psoriasis	8e-05	0.000408	CcSEcCtD
Etoposide—Fatigue—Triamcinolone—psoriasis	8e-05	0.000408	CcSEcCtD
Etoposide—ABCB1—Allograft Rejection—IL17A—psoriasis	7.98e-05	0.00261	CbGpPWpGaD
Etoposide—Hypersensitivity—Mycophenolate mofetil—psoriasis	7.97e-05	0.000407	CcSEcCtD
Etoposide—Asthenia—Cyclosporine—psoriasis	7.95e-05	0.000406	CcSEcCtD
Etoposide—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	7.94e-05	0.00259	CbGpPWpGaD
Etoposide—Pain—Triamcinolone—psoriasis	7.93e-05	0.000405	CcSEcCtD
Etoposide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—psoriasis	7.91e-05	0.00258	CbGpPWpGaD
Etoposide—Loss of consciousness—Prednisone—psoriasis	7.89e-05	0.000403	CcSEcCtD
Etoposide—TOP2A—Cell Cycle—PTTG1—psoriasis	7.88e-05	0.00257	CbGpPWpGaD
Etoposide—Hypotension—Dexamethasone—psoriasis	7.86e-05	0.000401	CcSEcCtD
Etoposide—Hypotension—Betamethasone—psoriasis	7.86e-05	0.000401	CcSEcCtD
Etoposide—Pruritus—Cyclosporine—psoriasis	7.84e-05	0.0004	CcSEcCtD
Etoposide—Urticaria—Hydrocortisone—psoriasis	7.83e-05	0.000399	CcSEcCtD
Etoposide—Angiopathy—Methotrexate—psoriasis	7.82e-05	0.000399	CcSEcCtD
Etoposide—Immune system disorder—Methotrexate—psoriasis	7.79e-05	0.000398	CcSEcCtD
Etoposide—Abdominal pain—Hydrocortisone—psoriasis	7.79e-05	0.000398	CcSEcCtD
Etoposide—Body temperature increased—Hydrocortisone—psoriasis	7.79e-05	0.000398	CcSEcCtD
Etoposide—Convulsion—Prednisone—psoriasis	7.78e-05	0.000397	CcSEcCtD
Etoposide—Mediastinal disorder—Methotrexate—psoriasis	7.77e-05	0.000397	CcSEcCtD
Etoposide—Asthenia—Mycophenolate mofetil—psoriasis	7.76e-05	0.000396	CcSEcCtD
Etoposide—Hypertension—Prednisone—psoriasis	7.75e-05	0.000396	CcSEcCtD
Etoposide—Chills—Methotrexate—psoriasis	7.74e-05	0.000395	CcSEcCtD
Etoposide—Pruritus—Mycophenolate mofetil—psoriasis	7.65e-05	0.000391	CcSEcCtD
Etoposide—Feeling abnormal—Triamcinolone—psoriasis	7.64e-05	0.00039	CcSEcCtD
Etoposide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.63e-05	0.00249	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—CYP2S1—psoriasis	7.62e-05	0.00249	CbGpPWpGaD
Etoposide—Alopecia—Methotrexate—psoriasis	7.62e-05	0.000389	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	7.59e-05	0.000388	CcSEcCtD
Etoposide—Diarrhoea—Cyclosporine—psoriasis	7.58e-05	0.000387	CcSEcCtD
Etoposide—Paraesthesia—Dexamethasone—psoriasis	7.56e-05	0.000386	CcSEcCtD
Etoposide—Paraesthesia—Betamethasone—psoriasis	7.56e-05	0.000386	CcSEcCtD
Etoposide—Discomfort—Prednisone—psoriasis	7.55e-05	0.000386	CcSEcCtD
Etoposide—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	7.46e-05	0.00244	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—CRP—psoriasis	7.44e-05	0.00243	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—CAT—psoriasis	7.43e-05	0.00243	CbGpPWpGaD
Etoposide—Hypersensitivity—Prednisolone—psoriasis	7.43e-05	0.000379	CcSEcCtD
Etoposide—ABCB1—Allograft Rejection—IL12B—psoriasis	7.42e-05	0.00242	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	7.42e-05	0.00242	CbGpPWpGaD
Etoposide—Diarrhoea—Mycophenolate mofetil—psoriasis	7.4e-05	0.000378	CcSEcCtD
Etoposide—Urticaria—Triamcinolone—psoriasis	7.37e-05	0.000376	CcSEcCtD
Etoposide—PTGS2—Overview of nanoparticle effects—IL6—psoriasis	7.35e-05	0.0024	CbGpPWpGaD
Etoposide—Dysgeusia—Methotrexate—psoriasis	7.35e-05	0.000375	CcSEcCtD
Etoposide—Body temperature increased—Triamcinolone—psoriasis	7.33e-05	0.000374	CcSEcCtD
Etoposide—Dizziness—Cyclosporine—psoriasis	7.33e-05	0.000374	CcSEcCtD
Etoposide—Anaphylactic shock—Prednisone—psoriasis	7.33e-05	0.000374	CcSEcCtD
Etoposide—Decreased appetite—Betamethasone—psoriasis	7.32e-05	0.000373	CcSEcCtD
Etoposide—Decreased appetite—Dexamethasone—psoriasis	7.32e-05	0.000373	CcSEcCtD
Etoposide—Infection—Prednisone—psoriasis	7.28e-05	0.000372	CcSEcCtD
Etoposide—Gastrointestinal disorder—Dexamethasone—psoriasis	7.27e-05	0.000371	CcSEcCtD
Etoposide—Gastrointestinal disorder—Betamethasone—psoriasis	7.27e-05	0.000371	CcSEcCtD
Etoposide—Back pain—Methotrexate—psoriasis	7.26e-05	0.000371	CcSEcCtD
Etoposide—Hypersensitivity—Hydrocortisone—psoriasis	7.26e-05	0.00037	CcSEcCtD
Etoposide—Fatigue—Betamethasone—psoriasis	7.26e-05	0.00037	CcSEcCtD
Etoposide—Fatigue—Dexamethasone—psoriasis	7.26e-05	0.00037	CcSEcCtD
Etoposide—ABCB1—Allograft Rejection—HLA-E—psoriasis	7.24e-05	0.00236	CbGpPWpGaD
Etoposide—Pain—Dexamethasone—psoriasis	7.2e-05	0.000367	CcSEcCtD
Etoposide—Pain—Betamethasone—psoriasis	7.2e-05	0.000367	CcSEcCtD
Etoposide—Tachycardia—Prednisone—psoriasis	7.15e-05	0.000365	CcSEcCtD
Etoposide—Dizziness—Mycophenolate mofetil—psoriasis	7.15e-05	0.000365	CcSEcCtD
Etoposide—Skin disorder—Prednisone—psoriasis	7.12e-05	0.000363	CcSEcCtD
Etoposide—Hyperhidrosis—Prednisone—psoriasis	7.09e-05	0.000362	CcSEcCtD
Etoposide—CYP1A2—Tryptophan metabolism—CAT—psoriasis	7.07e-05	0.00231	CbGpPWpGaD
Etoposide—Asthenia—Hydrocortisone—psoriasis	7.07e-05	0.000361	CcSEcCtD
Etoposide—Vomiting—Cyclosporine—psoriasis	7.05e-05	0.00036	CcSEcCtD
Etoposide—Rash—Cyclosporine—psoriasis	6.99e-05	0.000357	CcSEcCtD
Etoposide—Anorexia—Prednisone—psoriasis	6.99e-05	0.000357	CcSEcCtD
Etoposide—Dermatitis—Cyclosporine—psoriasis	6.98e-05	0.000356	CcSEcCtD
Etoposide—Pruritus—Hydrocortisone—psoriasis	6.97e-05	0.000356	CcSEcCtD
Etoposide—Ill-defined disorder—Methotrexate—psoriasis	6.96e-05	0.000355	CcSEcCtD
Etoposide—Headache—Cyclosporine—psoriasis	6.94e-05	0.000354	CcSEcCtD
Etoposide—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	6.94e-05	0.00226	CbGpPWpGaD
Etoposide—Anaemia—Methotrexate—psoriasis	6.94e-05	0.000354	CcSEcCtD
Etoposide—Feeling abnormal—Dexamethasone—psoriasis	6.94e-05	0.000354	CcSEcCtD
Etoposide—Feeling abnormal—Betamethasone—psoriasis	6.94e-05	0.000354	CcSEcCtD
Etoposide—Gastrointestinal pain—Betamethasone—psoriasis	6.88e-05	0.000351	CcSEcCtD
Etoposide—Gastrointestinal pain—Dexamethasone—psoriasis	6.88e-05	0.000351	CcSEcCtD
Etoposide—Vomiting—Mycophenolate mofetil—psoriasis	6.88e-05	0.000351	CcSEcCtD
Etoposide—PTGS1—Selenium Micronutrient Network—ICAM1—psoriasis	6.83e-05	0.00223	CbGpPWpGaD
Etoposide—Hypersensitivity—Triamcinolone—psoriasis	6.83e-05	0.000349	CcSEcCtD
Etoposide—Rash—Mycophenolate mofetil—psoriasis	6.82e-05	0.000348	CcSEcCtD
Etoposide—Dermatitis—Mycophenolate mofetil—psoriasis	6.81e-05	0.000348	CcSEcCtD
Etoposide—GSTT1—Metabolism—CARM1—psoriasis	6.79e-05	0.00222	CbGpPWpGaD
Etoposide—Headache—Mycophenolate mofetil—psoriasis	6.77e-05	0.000346	CcSEcCtD
Etoposide—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	6.77e-05	0.00221	CbGpPWpGaD
Etoposide—Malaise—Methotrexate—psoriasis	6.77e-05	0.000345	CcSEcCtD
Etoposide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.75e-05	0.0022	CbGpPWpGaD
Etoposide—Vertigo—Methotrexate—psoriasis	6.74e-05	0.000344	CcSEcCtD
Etoposide—Diarrhoea—Hydrocortisone—psoriasis	6.74e-05	0.000344	CcSEcCtD
Etoposide—Leukopenia—Methotrexate—psoriasis	6.72e-05	0.000343	CcSEcCtD
Etoposide—Urticaria—Betamethasone—psoriasis	6.69e-05	0.000341	CcSEcCtD
Etoposide—Urticaria—Dexamethasone—psoriasis	6.69e-05	0.000341	CcSEcCtD
Etoposide—Dizziness—Prednisolone—psoriasis	6.67e-05	0.00034	CcSEcCtD
Etoposide—Asthenia—Triamcinolone—psoriasis	6.66e-05	0.00034	CcSEcCtD
Etoposide—Body temperature increased—Betamethasone—psoriasis	6.65e-05	0.00034	CcSEcCtD
Etoposide—Body temperature increased—Dexamethasone—psoriasis	6.65e-05	0.00034	CcSEcCtD
Etoposide—Abdominal pain—Betamethasone—psoriasis	6.65e-05	0.00034	CcSEcCtD
Etoposide—Abdominal pain—Dexamethasone—psoriasis	6.65e-05	0.00034	CcSEcCtD
Etoposide—Nausea—Cyclosporine—psoriasis	6.58e-05	0.000336	CcSEcCtD
Etoposide—Paraesthesia—Prednisone—psoriasis	6.58e-05	0.000336	CcSEcCtD
Etoposide—Pruritus—Triamcinolone—psoriasis	6.56e-05	0.000335	CcSEcCtD
Etoposide—Cough—Methotrexate—psoriasis	6.55e-05	0.000334	CcSEcCtD
Etoposide—Dizziness—Hydrocortisone—psoriasis	6.51e-05	0.000333	CcSEcCtD
Etoposide—Convulsion—Methotrexate—psoriasis	6.5e-05	0.000332	CcSEcCtD
Etoposide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—psoriasis	6.49e-05	0.00212	CbGpPWpGaD
Etoposide—Nausea—Mycophenolate mofetil—psoriasis	6.42e-05	0.000328	CcSEcCtD
Etoposide—TOP2A—Circadian rythm related genes—LEP—psoriasis	6.42e-05	0.0021	CbGpPWpGaD
Etoposide—Chest pain—Methotrexate—psoriasis	6.39e-05	0.000326	CcSEcCtD
Etoposide—Decreased appetite—Prednisone—psoriasis	6.37e-05	0.000325	CcSEcCtD
Etoposide—Rash—Prednisolone—psoriasis	6.36e-05	0.000325	CcSEcCtD
Etoposide—Dermatitis—Prednisolone—psoriasis	6.35e-05	0.000324	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	6.35e-05	0.000324	CcSEcCtD
Etoposide—CYP3A4—Biological oxidations—CYP2S1—psoriasis	6.32e-05	0.00206	CbGpPWpGaD
Etoposide—Fatigue—Prednisone—psoriasis	6.32e-05	0.000323	CcSEcCtD
Etoposide—Headache—Prednisolone—psoriasis	6.32e-05	0.000323	CcSEcCtD
Etoposide—Discomfort—Methotrexate—psoriasis	6.31e-05	0.000322	CcSEcCtD
Etoposide—Constipation—Prednisone—psoriasis	6.27e-05	0.00032	CcSEcCtD
Etoposide—Vomiting—Hydrocortisone—psoriasis	6.26e-05	0.00032	CcSEcCtD
Etoposide—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	6.24e-05	0.00204	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	6.23e-05	0.00203	CbGpPWpGaD
Etoposide—Rash—Hydrocortisone—psoriasis	6.21e-05	0.000317	CcSEcCtD
Etoposide—Dermatitis—Hydrocortisone—psoriasis	6.21e-05	0.000317	CcSEcCtD
Etoposide—Confusional state—Methotrexate—psoriasis	6.18e-05	0.000315	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Hydrocortisone—psoriasis	6.17e-05	0.015	CbGdCrCtD
Etoposide—Headache—Hydrocortisone—psoriasis	6.17e-05	0.000315	CcSEcCtD
Etoposide—Dizziness—Triamcinolone—psoriasis	6.13e-05	0.000313	CcSEcCtD
Etoposide—Anaphylactic shock—Methotrexate—psoriasis	6.13e-05	0.000313	CcSEcCtD
Etoposide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.09e-05	0.00199	CbGpPWpGaD
Etoposide—Infection—Methotrexate—psoriasis	6.09e-05	0.000311	CcSEcCtD
Etoposide—Feeling abnormal—Prednisone—psoriasis	6.04e-05	0.000308	CcSEcCtD
Etoposide—Asthenia—Dexamethasone—psoriasis	6.04e-05	0.000308	CcSEcCtD
Etoposide—Asthenia—Betamethasone—psoriasis	6.04e-05	0.000308	CcSEcCtD
Etoposide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—psoriasis	6.03e-05	0.00197	CbGpPWpGaD
Etoposide—Thrombocytopenia—Methotrexate—psoriasis	6e-05	0.000306	CcSEcCtD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	5.99e-05	0.00196	CbGpPWpGaD
Etoposide—Gastrointestinal pain—Prednisone—psoriasis	5.99e-05	0.000306	CcSEcCtD
Etoposide—Nausea—Prednisolone—psoriasis	5.99e-05	0.000306	CcSEcCtD
Etoposide—TOP2A—Circadian rythm related genes—NOS2—psoriasis	5.98e-05	0.00195	CbGpPWpGaD
Etoposide—Pruritus—Dexamethasone—psoriasis	5.95e-05	0.000304	CcSEcCtD
Etoposide—Pruritus—Betamethasone—psoriasis	5.95e-05	0.000304	CcSEcCtD
Etoposide—Skin disorder—Methotrexate—psoriasis	5.95e-05	0.000304	CcSEcCtD
Etoposide—Hyperhidrosis—Methotrexate—psoriasis	5.92e-05	0.000302	CcSEcCtD
Etoposide—PTGS2—Selenium Micronutrient Network—CRP—psoriasis	5.9e-05	0.00193	CbGpPWpGaD
Etoposide—Vomiting—Triamcinolone—psoriasis	5.9e-05	0.000301	CcSEcCtD
Etoposide—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	5.89e-05	0.00192	CbGpPWpGaD
Etoposide—Nausea—Hydrocortisone—psoriasis	5.85e-05	0.000299	CcSEcCtD
Etoposide—Rash—Triamcinolone—psoriasis	5.85e-05	0.000299	CcSEcCtD
Etoposide—Dermatitis—Triamcinolone—psoriasis	5.84e-05	0.000298	CcSEcCtD
Etoposide—Anorexia—Methotrexate—psoriasis	5.84e-05	0.000298	CcSEcCtD
Etoposide—Urticaria—Prednisone—psoriasis	5.82e-05	0.000297	CcSEcCtD
Etoposide—Headache—Triamcinolone—psoriasis	5.81e-05	0.000297	CcSEcCtD
Etoposide—Abdominal pain—Prednisone—psoriasis	5.79e-05	0.000296	CcSEcCtD
Etoposide—Body temperature increased—Prednisone—psoriasis	5.79e-05	0.000296	CcSEcCtD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	5.77e-05	0.00188	CbGpPWpGaD
Etoposide—Diarrhoea—Dexamethasone—psoriasis	5.76e-05	0.000294	CcSEcCtD
Etoposide—Diarrhoea—Betamethasone—psoriasis	5.76e-05	0.000294	CcSEcCtD
Etoposide—Hypotension—Methotrexate—psoriasis	5.72e-05	0.000292	CcSEcCtD
Etoposide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	5.61e-05	0.00183	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—PPARG—psoriasis	5.59e-05	0.00183	CbGpPWpGaD
Etoposide—Dizziness—Dexamethasone—psoriasis	5.57e-05	0.000284	CcSEcCtD
Etoposide—Dizziness—Betamethasone—psoriasis	5.57e-05	0.000284	CcSEcCtD
Etoposide—ABCC3—Metabolism—NDUFA5—psoriasis	5.54e-05	0.00181	CbGpPWpGaD
Etoposide—Nausea—Triamcinolone—psoriasis	5.51e-05	0.000281	CcSEcCtD
Etoposide—Paraesthesia—Methotrexate—psoriasis	5.5e-05	0.000281	CcSEcCtD
Etoposide—Dyspnoea—Methotrexate—psoriasis	5.46e-05	0.000279	CcSEcCtD
Etoposide—CYP3A4—Tryptophan metabolism—CAT—psoriasis	5.46e-05	0.00178	CbGpPWpGaD
Etoposide—Somnolence—Methotrexate—psoriasis	5.45e-05	0.000278	CcSEcCtD
Etoposide—PTGS2—Selenium Micronutrient Network—ICAM1—psoriasis	5.43e-05	0.00177	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—IL10—psoriasis	5.43e-05	0.00177	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—IL4—psoriasis	5.4e-05	0.00176	CbGpPWpGaD
Etoposide—Hypersensitivity—Prednisone—psoriasis	5.4e-05	0.000276	CcSEcCtD
Etoposide—Vomiting—Dexamethasone—psoriasis	5.35e-05	0.000273	CcSEcCtD
Etoposide—Vomiting—Betamethasone—psoriasis	5.35e-05	0.000273	CcSEcCtD
Etoposide—Decreased appetite—Methotrexate—psoriasis	5.33e-05	0.000272	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Prednisone—psoriasis	5.31e-05	0.0129	CbGdCrCtD
Etoposide—Rash—Dexamethasone—psoriasis	5.31e-05	0.000271	CcSEcCtD
Etoposide—Rash—Betamethasone—psoriasis	5.31e-05	0.000271	CcSEcCtD
Etoposide—Dermatitis—Betamethasone—psoriasis	5.3e-05	0.000271	CcSEcCtD
Etoposide—Dermatitis—Dexamethasone—psoriasis	5.3e-05	0.000271	CcSEcCtD
Etoposide—Gastrointestinal disorder—Methotrexate—psoriasis	5.29e-05	0.00027	CcSEcCtD
Etoposide—Fatigue—Methotrexate—psoriasis	5.28e-05	0.00027	CcSEcCtD
Etoposide—ABCB1—Allograft Rejection—IL4—psoriasis	5.28e-05	0.00172	CbGpPWpGaD
Etoposide—Headache—Betamethasone—psoriasis	5.27e-05	0.000269	CcSEcCtD
Etoposide—Headache—Dexamethasone—psoriasis	5.27e-05	0.000269	CcSEcCtD
Etoposide—Asthenia—Prednisone—psoriasis	5.26e-05	0.000268	CcSEcCtD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.24e-05	0.00171	CbGpPWpGaD
Etoposide—Pain—Methotrexate—psoriasis	5.24e-05	0.000267	CcSEcCtD
Etoposide—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	5.2e-05	0.0017	CbGpPWpGaD
Etoposide—TOP2A—Methyltestosterone—Prednisolone—psoriasis	5.19e-05	0.0126	CbGdCrCtD
Etoposide—Pruritus—Prednisone—psoriasis	5.19e-05	0.000265	CcSEcCtD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.16e-05	0.00169	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—HLA-B—psoriasis	5.16e-05	0.00168	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	5.15e-05	0.00168	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—CP—psoriasis	5.15e-05	0.00168	CbGpPWpGaD
Etoposide—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	5.15e-05	0.00168	CbGpPWpGaD
Etoposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—psoriasis	5.12e-05	0.00167	CbGpPWpGaD
Etoposide—Feeling abnormal—Methotrexate—psoriasis	5.05e-05	0.000258	CcSEcCtD
Etoposide—Diarrhoea—Prednisone—psoriasis	5.02e-05	0.000256	CcSEcCtD
Etoposide—Gastrointestinal pain—Methotrexate—psoriasis	5.01e-05	0.000256	CcSEcCtD
Etoposide—Nausea—Dexamethasone—psoriasis	5e-05	0.000255	CcSEcCtD
Etoposide—Nausea—Betamethasone—psoriasis	5e-05	0.000255	CcSEcCtD
Etoposide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	4.93e-05	0.00161	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—CARM1—psoriasis	4.91e-05	0.0016	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—CXCL8—psoriasis	4.91e-05	0.0016	CbGpPWpGaD
Etoposide—Urticaria—Methotrexate—psoriasis	4.87e-05	0.000248	CcSEcCtD
Etoposide—Dizziness—Prednisone—psoriasis	4.85e-05	0.000247	CcSEcCtD
Etoposide—Abdominal pain—Methotrexate—psoriasis	4.84e-05	0.000247	CcSEcCtD
Etoposide—Body temperature increased—Methotrexate—psoriasis	4.84e-05	0.000247	CcSEcCtD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	4.8e-05	0.00157	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—HLA-A—psoriasis	4.78e-05	0.00156	CbGpPWpGaD
Etoposide—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	4.72e-05	0.00154	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—CYP2S1—psoriasis	4.71e-05	0.00154	CbGpPWpGaD
Etoposide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.7e-05	0.00153	CbGpPWpGaD
Etoposide—Vomiting—Prednisone—psoriasis	4.66e-05	0.000238	CcSEcCtD
Etoposide—Rash—Prednisone—psoriasis	4.62e-05	0.000236	CcSEcCtD
Etoposide—Dermatitis—Prednisone—psoriasis	4.62e-05	0.000236	CcSEcCtD
Etoposide—Headache—Prednisone—psoriasis	4.59e-05	0.000234	CcSEcCtD
Etoposide—PTGS2—Spinal Cord Injury—LEP—psoriasis	4.57e-05	0.00149	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—JUN—psoriasis	4.56e-05	0.00149	CbGpPWpGaD
Etoposide—Hypersensitivity—Methotrexate—psoriasis	4.51e-05	0.00023	CcSEcCtD
Etoposide—UGT1A1—Metabolism—NDUFA5—psoriasis	4.5e-05	0.00147	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.49e-05	0.00147	CbGpPWpGaD
Etoposide—Asthenia—Methotrexate—psoriasis	4.4e-05	0.000224	CcSEcCtD
Etoposide—GSTP1—Cellular responses to stress—NFKB1—psoriasis	4.39e-05	0.00143	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	4.37e-05	0.00143	CbGpPWpGaD
Etoposide—Nausea—Prednisone—psoriasis	4.35e-05	0.000222	CcSEcCtD
Etoposide—ABCC1—Metabolism—NDUFA5—psoriasis	4.34e-05	0.00142	CbGpPWpGaD
Etoposide—Pruritus—Methotrexate—psoriasis	4.33e-05	0.000221	CcSEcCtD
Etoposide—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	4.33e-05	0.00141	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—ICAM1—psoriasis	4.29e-05	0.0014	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—NOS2—psoriasis	4.26e-05	0.00139	CbGpPWpGaD
Etoposide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriasis	4.2e-05	0.00137	CbGpPWpGaD
Etoposide—Diarrhoea—Methotrexate—psoriasis	4.19e-05	0.000214	CcSEcCtD
Etoposide—GSTT1—Metabolism—CAT—psoriasis	4.18e-05	0.00136	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—CD4—psoriasis	4.14e-05	0.00135	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	4.13e-05	0.00135	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—IFNG—psoriasis	4.13e-05	0.00135	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	4.08e-05	0.00133	CbGpPWpGaD
Etoposide—Dizziness—Methotrexate—psoriasis	4.05e-05	0.000207	CcSEcCtD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.05e-05	0.00132	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—CP—psoriasis	4.03e-05	0.00132	CbGpPWpGaD
Etoposide—TOP2A—Norethindrone—Hydrocortisone—psoriasis	4.02e-05	0.0098	CbGdCrCtD
Etoposide—GSTP1—Cellular responses to stress—VEGFA—psoriasis	3.99e-05	0.0013	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.98e-05	0.0013	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—JUN—psoriasis	3.97e-05	0.0013	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—STAT3—psoriasis	3.95e-05	0.00129	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	3.93e-05	0.00128	CbGpPWpGaD
Etoposide—Vomiting—Methotrexate—psoriasis	3.89e-05	0.000199	CcSEcCtD
Etoposide—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	3.89e-05	0.00127	CbGpPWpGaD
Etoposide—Rash—Methotrexate—psoriasis	3.86e-05	0.000197	CcSEcCtD
Etoposide—Dermatitis—Methotrexate—psoriasis	3.86e-05	0.000197	CcSEcCtD
Etoposide—ABCC1—Transmembrane transport of small molecules—CARM1—psoriasis	3.85e-05	0.00126	CbGpPWpGaD
Etoposide—Headache—Methotrexate—psoriasis	3.84e-05	0.000196	CcSEcCtD
Etoposide—UGT1A1—Metabolism—CYP2S1—psoriasis	3.83e-05	0.00125	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—NDUFA5—psoriasis	3.82e-05	0.00125	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—CARM1—psoriasis	3.72e-05	0.00121	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CYP2S1—psoriasis	3.69e-05	0.0012	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—NDUFA5—psoriasis	3.67e-05	0.0012	CbGpPWpGaD
Etoposide—Nausea—Methotrexate—psoriasis	3.64e-05	0.000186	CcSEcCtD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	3.61e-05	0.00118	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—PCNA—psoriasis	3.59e-05	0.00117	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	3.55e-05	0.00116	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.45e-05	0.00113	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—NFKB1—psoriasis	3.44e-05	0.00112	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.42e-05	0.00112	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.39e-05	0.00111	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	3.39e-05	0.0011	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	3.37e-05	0.0011	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.27e-05	0.00107	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—IFNG—psoriasis	3.26e-05	0.00107	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP2S1—psoriasis	3.25e-05	0.00106	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—APOE—psoriasis	3.25e-05	0.00106	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—PCNA—psoriasis	3.21e-05	0.00105	CbGpPWpGaD
Etoposide—TOP2A—Levonorgestrel—Hydrocortisone—psoriasis	3.2e-05	0.0078	CbGdCrCtD
Etoposide—ABCB1—Allograft Rejection—IFNG—psoriasis	3.19e-05	0.00104	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.18e-05	0.00104	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP2S1—psoriasis	3.12e-05	0.00102	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	3.09e-05	0.00101	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	3.04e-05	0.000991	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—TP53—psoriasis	3.01e-05	0.000983	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.97e-05	0.000968	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.96e-05	0.000968	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—NDUFA5—psoriasis	2.91e-05	0.000951	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.9e-05	0.000945	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PPARG—psoriasis	2.83e-05	0.000923	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.78e-05	0.000908	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—IL6—psoriasis	2.76e-05	0.0009	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—NDUFA5—psoriasis	2.74e-05	0.000895	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—NDUFA5—psoriasis	2.74e-05	0.000893	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.73e-05	0.000891	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	2.72e-05	0.000887	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.72e-05	0.000886	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	2.67e-05	0.000872	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—TP53—psoriasis	2.62e-05	0.000855	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.54e-05	0.000829	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.54e-05	0.000829	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP2S1—psoriasis	2.48e-05	0.000808	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.47e-05	0.000805	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.44e-05	0.000797	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.41e-05	0.000786	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—IL6—psoriasis	2.4e-05	0.000783	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—NDUFA5—psoriasis	2.37e-05	0.000773	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP2S1—psoriasis	2.33e-05	0.000761	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP2S1—psoriasis	2.33e-05	0.000759	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—CARM1—psoriasis	2.3e-05	0.000751	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—CAT—psoriasis	2.29e-05	0.000747	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.21e-05	0.000721	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	2.16e-05	0.000704	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.15e-05	0.000702	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TNF—psoriasis	2.11e-05	0.00069	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—TNF—psoriasis	2.06e-05	0.000674	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NDUFA5—psoriasis	2.06e-05	0.000674	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.05e-05	0.00067	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP2S1—psoriasis	2.01e-05	0.000658	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.93e-05	0.000631	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.92e-05	0.000627	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.92e-05	0.000626	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CARM1—psoriasis	1.87e-05	0.00061	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TP53—psoriasis	1.86e-05	0.000608	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.85e-05	0.000603	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.83e-05	0.000597	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CARM1—psoriasis	1.8e-05	0.000588	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—APOE—psoriasis	1.78e-05	0.000581	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP2S1—psoriasis	1.76e-05	0.000573	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—IL6—psoriasis	1.71e-05	0.000557	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.68e-05	0.00055	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.68e-05	0.000547	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NDUFA5—psoriasis	1.65e-05	0.000538	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.63e-05	0.000534	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CARM1—psoriasis	1.59e-05	0.000518	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PPARG—psoriasis	1.55e-05	0.000506	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.54e-05	0.000502	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CARM1—psoriasis	1.52e-05	0.000497	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.44e-05	0.000469	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.42e-05	0.000465	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—CAT—psoriasis	1.41e-05	0.000462	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP2S1—psoriasis	1.4e-05	0.000457	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.36e-05	0.000444	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.31e-05	0.000428	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.3e-05	0.000424	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NDUFA5—psoriasis	1.27e-05	0.000415	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.27e-05	0.000414	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CARM1—psoriasis	1.21e-05	0.000395	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.19e-05	0.000388	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TP53—psoriasis	1.18e-05	0.000385	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CAT—psoriasis	1.15e-05	0.000375	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CARM1—psoriasis	1.14e-05	0.000372	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CARM1—psoriasis	1.14e-05	0.000371	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.13e-05	0.000369	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CAT—psoriasis	1.11e-05	0.000362	CbGpPWpGaD
Etoposide—ABCC1—Disease—HLA-A—psoriasis	1.1e-05	0.00036	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—APOE—psoriasis	1.1e-05	0.000359	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP2S1—psoriasis	1.08e-05	0.000353	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.06e-05	0.000345	CbGpPWpGaD
Etoposide—ABCC1—Disease—APOE—psoriasis	1.03e-05	0.000336	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.02e-05	0.000333	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CARM1—psoriasis	9.84e-06	0.000321	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CAT—psoriasis	9.75e-06	0.000318	CbGpPWpGaD
Etoposide—ABCC1—Disease—NOS2—psoriasis	9.58e-06	0.000313	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PPARG—psoriasis	9.57e-06	0.000312	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CAT—psoriasis	9.37e-06	0.000306	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.2e-06	0.0003	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.98e-06	0.000293	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—APOE—psoriasis	8.93e-06	0.000291	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—APOE—psoriasis	8.61e-06	0.000281	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CARM1—psoriasis	8.57e-06	0.00028	CbGpPWpGaD
Etoposide—ABCC1—Disease—TYK2—psoriasis	7.85e-06	0.000256	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PPARG—psoriasis	7.78e-06	0.000254	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—APOE—psoriasis	7.58e-06	0.000247	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PPARG—psoriasis	7.5e-06	0.000245	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CAT—psoriasis	7.44e-06	0.000243	CbGpPWpGaD
Etoposide—PTGS2—Disease—HLA-A—psoriasis	7.39e-06	0.000241	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.34e-06	0.00024	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—APOE—psoriasis	7.28e-06	0.000238	CbGpPWpGaD
Etoposide—ABCC1—Disease—CD4—psoriasis	7.1e-06	0.000232	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CAT—psoriasis	7e-06	0.000229	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CAT—psoriasis	6.99e-06	0.000228	CbGpPWpGaD
Etoposide—PTGS2—Disease—APOE—psoriasis	6.9e-06	0.000225	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CARM1—psoriasis	6.84e-06	0.000223	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PPARG—psoriasis	6.6e-06	0.000215	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOS2—psoriasis	6.43e-06	0.00021	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.4e-06	0.000209	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PPARG—psoriasis	6.34e-06	0.000207	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CAT—psoriasis	6.05e-06	0.000198	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—APOE—psoriasis	5.78e-06	0.000189	CbGpPWpGaD
Etoposide—ABCC1—Disease—STAT3—psoriasis	5.5e-06	0.000179	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—APOE—psoriasis	5.44e-06	0.000178	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—APOE—psoriasis	5.43e-06	0.000177	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CARM1—psoriasis	5.28e-06	0.000172	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CAT—psoriasis	5.27e-06	0.000172	CbGpPWpGaD
Etoposide—PTGS2—Disease—TYK2—psoriasis	5.27e-06	0.000172	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PPARG—psoriasis	5.03e-06	0.000164	CbGpPWpGaD
Etoposide—PTGS2—Disease—CD4—psoriasis	4.76e-06	0.000155	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PPARG—psoriasis	4.74e-06	0.000155	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PPARG—psoriasis	4.73e-06	0.000154	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—APOE—psoriasis	4.7e-06	0.000153	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CAT—psoriasis	4.21e-06	0.000137	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—APOE—psoriasis	4.1e-06	0.000134	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PPARG—psoriasis	4.1e-06	0.000134	CbGpPWpGaD
Etoposide—ABCC1—Disease—IL6—psoriasis	3.84e-06	0.000125	CbGpPWpGaD
Etoposide—PTGS2—Disease—STAT3—psoriasis	3.69e-06	0.00012	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PPARG—psoriasis	3.57e-06	0.000116	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—APOE—psoriasis	3.27e-06	0.000107	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CAT—psoriasis	3.25e-06	0.000106	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PPARG—psoriasis	2.85e-06	9.3e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6—psoriasis	2.58e-06	8.41e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—APOE—psoriasis	2.52e-06	8.24e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPARG—psoriasis	2.2e-06	7.18e-05	CbGpPWpGaD
